World Heart Day highlights the overlooked high risk of cardiovascular disease in Asian American, Native Hawaiian, and Pacific Islander communities, prompting updated clinical strategies to improve detection and treatment tailored to diverse ethnic groups.
World Heart Day is drawing attention to a longstanding blind spot in U.S. cardiovascular care: the burden of heart disease among Asian Americans, Native Hawaiians and Pacific Islanders. Healio reports that more than half of Asian American men and nearly 40% of Asian American women are living with cardiovascular disease, a reminder that these communities are not protected from the nation’s leading cause of death. The American Heart Association has also warned that broad labels can obscure major differences between subgroups, making it harder to spot who is at greatest risk and who may be slipping through the cracks.
The scale of the problem is heightened by uneven rates of diabetes, hypertension, abnormal cholesterol and obesity. In its reporting on the issue, the American Heart Association has noted that Asian communities in the United States include more than 50 ethnicities and more than 100 languages, which makes aggregated data a poor guide for clinical care. That matters because some groups face earlier and more aggressive disease. South Asian populations, for example, are more likely to develop coronary artery disease and heart attacks at younger ages, while East and Southeast Asian communities have comparatively high stroke risk, often tied to uncontrolled blood pressure.
Clinicians are being urged to adjust their screening thresholds and treatment plans accordingly. Healio says the new clinical guide recommends diabetes screening for Asian patients starting at a body mass index of 23, rather than the more familiar 25, because Asian populations are considered overweight at a lower threshold. The guidance also calls for routine checks of blood pressure, lipids and lipoprotein(a), a genetic risk marker linked to heart disease. For younger South Asian and Filipino adults with multiple risk factors, the guide suggests coronary artery calcium scoring in select cases to help estimate atherosclerotic risk more accurately.
Medication choice is another area where ethnicity can matter. Healio reports that some East Asian patients metabolise statins more slowly, increasing the risk of severe side effects, so lower doses or alternative therapies may be appropriate. The guide also highlights a high prevalence of CYP2C19 loss-of-function variants in many Asian and Pacific Islander groups, which can make clopidogrel less effective. Beyond prescribing, the message is broader: data should be broken down by ethnicity, cultural eating patterns should be addressed directly, and social factors such as insurance, education and employment should be considered in prevention and treatment. The American Heart Association has said these steps are necessary to narrow gaps that have too often remained hidden inside larger racial categories.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
